Almost a thousand patients have so far received the antiviral pill Molnupiravir in Cyprus for treatment of Covid 19, the Deputy Director of Pharmaceutical Services of the Ministry of Health, Elena Papanagiotopoulou, told CNA.
According to Dr Panagiotopoulou, Merck's Molnupiravir, known in Europe as MSD, has so far been administered to 984 patients, with 7% eventually ending up in hospital.
(CNA)
CNA - Emily Lambrou
Contents of this article including associated images are owned by CNA
Views & opinions expressed are those of the author and/or CNA
Source
